Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…
Scandinavian ChemoTech AB’s Shares Offering


Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…
…